About Scout Bio
Scout Bio is a company based in Philadelphia (United States) founded in 2017 was acquired by Ceva in January 2024. Scout Bio has raised $29.3 million across 2 funding rounds from investors including Ceva, Frazier Healthcare Partners and Greenspring Associates. Scout Bio offers products and services including AAV Vector Gene Therapy and Therapy for CKD Anemia.
- Headquarter Philadelphia, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Scout Bio, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Scout Bio
Scout Bio offers a comprehensive portfolio of products and services, including AAV Vector Gene Therapy and Therapy for CKD Anemia.
One-time injection for long-lasting expression of therapeutic proteins in pets
Targets anemia in cats with chronic kidney disease through gene transfer
People of Scout Bio
Unlock access to complete
Operations Team
1 people
Finance and Accounting
1 people
Leadership Team
1 people
Senior Team
1 people
Unlock access to complete
Funding Insights of Scout Bio
Scout Bio has successfully raised a total of $29.3M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $20 million completed in April 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Scout Bio
Scout Bio has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Ceva, Frazier Healthcare Partners and Greenspring Associates.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment in animal health innovation is facilitated by Digitalis Ventures.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Diversified investment management firm
|
Locked | Locked | Locked |
Investor details for Scout Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Scout Bio
Investment portfolio details for Scout Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Scout Bio
Detailed financials for Scout Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Scout Bio Comparisons
Peer comparison for Scout Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Scout Bio
Detailed competitors of Scout Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Scout Bio
Complete news archive for Scout Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Scout Bio
Scout Bio was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Scout Bio is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Mark Heffernan is the current CEO of Scout Bio.
Scout Bio is a funded company, having raised a total of $29.3M across 2 funding rounds to date.
Scout Bio was founded in 2017 in Philadelphia, United States, within the biotechnology sector focused on animal health. Gene therapy technologies are developed to address chronic conditions in pets through protein therapeutics. An adeno-associated viral (AAV) vector process is utilized, involving intramuscular injections to enable expression of therapeutic proteins. Operations center on advancing these treatments for veterinary applications.
Scout Bio offers AAV Vector Gene Therapy and Therapy for CKD Anemia.
Scout Bio has 7 investors. Key investors include Ceva, Frazier Healthcare Partners, Greenspring Associates, Digitalis Ventures, and RiverVest Venture Partners.